Axiom MRC has updated all it's market research reports with the Economic Impact Analysis of COVID19 Pandemic on the market. Our team of analyst are following Comprehensive Three Dimensional (3D) Research Methodology along with large number primary interviews with key industry participants to bring insightful market reports to meet the current market requirements.
Animal models are those animals on which pathological and biological experiments are performed and tested. Animal models are implemented as animal and human beings share important physiological & organic structure. In addition, some of the animals species have similar genetic structure as humans. So, animal models are used by scientists and researcher to study and find cure for diseases, test the final medicinal drugs before it is used on humans and also for development of new products. Novel drugs are examined in animals for their safety and efficacy prior examination in humans.
The United States animal model market is observing rapid growth during forecast period of 2021 to 2027. The animal models are used for drug discovery and development, basic research and others. The key factors such as use of animal model in validation and target identification, toxicity and safety screening, drug screening and lead optimization and preclinical analyses of drug safety and efficacy is propelling growth of United States animal model market. Rising demand for an animal model to perform various studies is also boosting growth of United States animal model market. However, high cost of study and stringent regulatory framework is hampering growth of United States animal model market.
The exclusive COVID-19 impact analysis report by Axiom MRC provides a 3600 analysis of micro and macro-economic factors on the animal model market. In addition, complete analysis of changes on animal model expenditure, economic and international policies on supply and demand side. The report also studies the impact of pandemic on United States economies, international trade, business investments, GDP and marketing strategies of key players present in the market. The rising incidences of various diseases and viral infections such as COVID-19 increases the demand for animal models for research activity during COVID-19 period. The rising prevalence of infectious diseases is also boosting growth of animal model market during COVID-19 pandemics. The rising use of animal models for development of research activities is also boosting growth of animal model market during COVID-19 period.
The United States animal model market is bifurcated into the animal type, application and end user.
Based on anima type, the United States animal model market is segmented into the pigs, cats, mice, monkey, rabbit and other animal such as dog. In which cats and dogs are contributing to the growth of United States animal model market. The use of animal models is research industry is a result of advancement of knowledge for how disease is affecting animal and human. It has also led to treatment of symptoms or in most of cases disease cure.
Based on application, the United States animal model market is bifurcated into the research and development, production and quality control. In which research and development segment is estimated to dominate the market in 2020. The rising research and development activities in the field of healthcare is propelling growth of United States animal model market. The increasing development of novel molecules for the treatment of chronic diseases is also boosting growth of United States animal model market. The growing use of animals in testing of new molecules is also refuelling growth of United States animal model market.
Based on end users, the United States animal model market is categorised into research institutes, pharmaceutical companies, contract research organizations and educational institutes. In which research institutes are likely to dominate the market in 2020. The rising demand of development of novel derivatives for infectious diseases is boosting growth of United States animal model market. The rising research for development of vaccines against the COVID-19 virus is also driving growth of United States animal model market.
The North America animal model is studied for key countries such as United States, Mexico and Canada. In which United States is anticipated to dominate the market in 2020. The rising disposable income is propelling growth of North America animal model market. The growing prevalence of chronic diseases is also boosting growth of North America animal model market. The rising demand for drug safety data is also refuelling growth of North America animal model market.
The key players comprised in animal model market are Janvier Labs, Charles River Laboratories, Genoway S.A., Envigo, Taconic Laboratories, Transgenic Inc., Sage Labs, Horizon Discovery, Crown Bioscience Inc. and Harbor Antibodies Bv (A Subsidiary Of Harbor Biomed) among others.
Apr 2021: Horizon Discovery is shared that IGM Biosciences, a clinical-stage biotechnology company focused on creating and developing engineered IgM antibodies has signed a multi-license commercial agreement within two years of their first license for the continued use of the Horizons cGMP-compliant CHO SOURCE platform for further development of IGM’s novel therapeutic IgM antibodies.
January 2020: Horizon Discovery Group plc (Horizon or the Group), a global leader in the application of gene editing and gene modulation technologies, has announced the collaboration and license agreement with Mammoth Biosciences (Mammoth or the Company), for access of Mammoth’s novel CRISPR platform and thereby facilitate delivery of a new generation of genetically engineered CHO cells for the production of biotherapeutics such as therapeutic antibodies.
December 2019: Horizon Discovery Group plc (Horizon), a global leader in the application of gene editing and gene modulation for cell line engineering, announced their partnership with The Human Protein Atlas (HPA). HPA has selected Horizon’s CRISPR-edited knockout cell models to further expand the knowledge available in its Cell Atlas program, to advance our understanding of the genetic drivers of disease.
September 2019: Horizon Discovery Group plc (Horizon), a global leader in the application of gene editing and gene modulation for cell line engineering, today announced the full commercial licensing to Glen Mark Pharmaceuticals, a global innovative pharmaceutical company, for its gene-edited Glutamine Synthetizes (GS) knockout Chinese Hamster Ovary (CHO) K1 cell line. Terms of the agreement were based on stringent evaluation of the cell line by Glen mark to assess its suitability for adoption into the Company’s biomanufacturing processes.
March 2019: Horizon Discovery Group plc (Horizon), a global leader in gene editing and gene modulation technologies, announced their collaboration with St George’s University Hospital, London, and the European Molecular Genetics Quality Network (EMQN), based within the Manchester Centre for Genomic Medicine at Saint Mary’s Hospital, to develop reference material for non-invasive prenatal testing (NIPT)
The report analyses the animal model market based on animal type, application, end user and country. The various types of animals covered in the report are pigs, cats, mice, monkey, rabbit and other animal such as dog. By application, the market is segmented into research and development and production and quality control. Based on end user, the market is segmented into research institutes, pharmaceutical companies, contract research organizations and educational institutes. The report also covered the impact of COVID-19 on the animal model market and it is found that the rising incidences of various diseases and viral infections such as COVID-19 increases the demand for animal models for research activity during COVID-19 period. The rising prevalence of infectious diseases is also boosting growth of animal model market during COVID-19 pandemics. The rising use of animal models for development of research activities is also boosting growth of animal model market during COVID-19 period. The report also covers the major key players operating in the market.
Why to buy this report
